GlassScriptPhysician profile
James Kiely
NPI 1467536383
$6,919.60
in general payments reported to CMS, 2019-2025
16 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.38 · 2020: $23.95 · 2021: $5,789 · 2022: $403 · 2023: $389 · 2024: $81.39 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,628.50 | 2020-2022 | |
| Sanara Medtech INC. | $360.56 | 2021-2023 | Celleraterx |
| Davol INC. | $233.70 | 2019-2025 | Phasix Mesh |
| Medtronic, INC. | $169.52 | 2021-2024 | Gi Genius |
| Lexington Medical, INC. | $91.57 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Ethicon US, LLC | $70.47 | 2021-2023 | Echelon Circular, Vistaseal |
| Kerecis Limited | $63.89 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Apollo Endosurgery US INC | $54.69 | 2023 | Overstitch Endoscopic Suturing System |
| Smith+Nephew, INC. | $43.37 | 2023-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Pacira Pharmaceuticals Incorporated | $36.49 | 2021-2022 | |
| Abbvie INC. | $36.10 | 2019 | |
| Integra Lifesciences Corporation | $35.66 | 2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Thd America, INC. | $28.77 | 2021-2023 | |
| Convatec INC. | $24.59 | 2019 | |
| Mimedx Group, INC. | $21.74 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $19.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kiely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.